Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. KPRX
KPRX logo

KPRX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KPRX News

Kiora Pharmaceuticals Secures $24 Million Financing to Advance Eye Disease Treatments

Apr 07 2026stocktwits

KIORA PHARMACEUTICALS INC TO OFFER 438,471 COMMON STOCK SHARES THROUGH PRIVATE PLACEMENT - SEC FILING

Apr 07 2026moomoo

Kiora Pharmaceuticals Reports FY 2025 Financial Results

Mar 25 2026seekingalpha

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

Oct 30 2025PRnewswire

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

Mar 28 2025Benzinga

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

Nov 12 2024Benzinga

Kiora Pharmaceuticals gets approval to initiate mid-stage trial for eye disorder treatment

Oct 29 2024SeekingAlpha

Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress

Aug 10 2024Business Insider

KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q2 2024

Aug 09 2024Business Insider

HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Adjusts Price Target To $10 (1-9 Reverse Stock Split)

Jul 23 2024Benzinga

Buy Rating on Kiora Pharmaceuticals Amid Strong Financials and Promising Clinical Trials

May 11 2024Business Insider

KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q1 2024

May 10 2024Business Insider

Kiora Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update

Nov 14 2021globenewswire

Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Feb 02 2024Benzinga

Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Feb 02 2024Benzinga

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Feb 01 2024Benzinga